Product Description
Overall, the Global Peripherally Inserted Central Catheter (PICC) market was valued slightly over $840 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.9% to reach $1.1 billion.
Throughout this medical market research, we analyzed over 12 peripherally inserted central catheter companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for implantable ports includes single-, double- and triple-lumen PICCs. They can also be segmented into non-power-injectable PICCs and power-injectable PICCs. The market for PICCs by tip-placement type includes tip-placement PICC kits and conventional (basic) PICC kits. Tip-placement PICC kits are any PICC kits that contain the necessary tip-placement disposables required for use with a tip-placement system.
DATA TYPES INCLUDED
- Unit Sales, Procedure Numbers, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Peripherally Inserted Central Catheter (PICC) Market Insights
In the ever-evolving peripherally inserted central catheter (PICC) market, the drive to innovate has given rise to a variety of specialized products. This includes valved PICCs, power-injectable PICCs, triple-lumen PICCs, and PICCs with antimicrobial and antithrombogenic properties. Moreover, continuous efforts are being made to enhance existing products. These advancements in PICC design are poised to reduce infection and complication rates while enhancing patient comfort. Concurrently, companies are dedicating their attention to the creation of products that complement ultrasound guidance, like ultrasound gel and probe covers.
Global Peripherally Inserted Central Catheter Market Share Insights
- BD leads the PICC market due to its extensive product range and tip-confirmation technology. They also focus on nurse-driven PICC placements and expanding into emerging markets. BD’s product portfolio, including the POWERPICC® catheter and others, is further strengthened by the recent acquisition of Bard’s product line. Their dominance is particularly evident in the triple-lumen PICC market and their revenue from tip-guidance PICC kits used with Sherlock tip-placement systems.
- Teleflex, the second-largest player in the PICC market, inherited Arrow International’s product line. While its power-injectable PICCs and triple-lumen variants have been strong, they haven’t reached the same level of success as BD. Teleflex’s ARROW® PICCs with Chlorag+ard® Technology, featuring antimicrobial and antithrombotic properties, hold potential to influence its future market share. Additionally, Teleflex has a significant presence in the CVC market, which can aid its expansion into other vascular access segments.
- AngioDynamics holds the third position in the PICC market and has found success with its antithrombogenic BioFlo® PICC product series. Similar to Teleflex, AngioDynamics has filed an antitrust lawsuit against BD, alleging that BD ties tip location systems to PICC sales. This legal dispute is ongoing and has an impact on the dynamics of the market.
Market Segmentation Summary
- Global Peripherally Inserted Central Catheter Market – Segmented by:
- Lumen Type: Single, Double, and Triple
- Device Type: Power-Injectable, Non-Power Injectable
- Kit Type: Tip-Placement Kit, Conventional Kit
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
